{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:14:47Z","timestamp":1787062487306,"version":"build-2736575974"},"reference-count":53,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,22]],"date-time":"2021-02-22T00:00:00Z","timestamp":1613952000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2016\/T1-BIO-1854"],"award-info":[{"award-number":["2016\/T1-BIO-1854"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1061332"],"award-info":[{"award-number":["APP1061332"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1064533"],"award-info":[{"award-number":["APP1064533"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.celrep.2021.108851","type":"journal-article","created":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T17:16:01Z","timestamp":1616087761000},"page":"108851","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["LXR stimulates a metabolic switch and reveals cholesterol homeostasis as a statin target in Tasmanian devil facial tumor disease"],"prefix":"10.1016","volume":"34","author":[{"given":"Maria P.","family":"Ikonomopoulou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaiza","family":"Lopez-Manche\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta G.","family":"Novelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maite","family":"Martinez-U\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lahiru","family":"Gangoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Filipe","family":"Costa-Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo Jose","family":"Fernandez-Marcos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant A.","family":"Ramm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel Alejandro","family":"Fernandez-Rojo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2021.108851_bib1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.cell.2008.04.052","article-title":"LXR signaling couples sterol metabolism to proliferation in the acquired immune response","volume":"134","author":"Bensinger","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2021.108851_bib2","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.cmet.2015.03.002","article-title":"Uncoupling nuclear receptor LXR and cholesterol metabolism in cancer","volume":"21","author":"Bovenga","year":"2015","journal-title":"Cell Metab."},{"key":"10.1016\/j.celrep.2021.108851_bib3","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/icb.2016.38","article-title":"Mitogen-activated Tasmanian devil blood mononuclear cells kill devil facial tumour disease cells","volume":"94","author":"Brown","year":"2016","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.celrep.2021.108851_bib4","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nrm3312","article-title":"Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR","volume":"13","author":"Calkin","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.celrep.2021.108851_bib5","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s11745-009-3305-7","article-title":"Cholesterol synthesis inhibitor U18666A and the role of sterol metabolism and trafficking in numerous pathophysiological processes","volume":"44","author":"Cenedella","year":"2009","journal-title":"Lipids"},{"key":"10.1016\/j.celrep.2021.108851_bib6","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.bbrc.2005.12.137","article-title":"Niemann-Pick C1 like 1 gene expression is down-regulated by LXR activators in the intestine","volume":"340","author":"Duval","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.celrep.2021.108851_bib7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41420-018-0030-0","article-title":"Gomesin peptides prevent proliferation and lead to the cell death of devil facial tumour disease cells","volume":"4","author":"Fernandez-Rojo","year":"2018","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.celrep.2021.108851_bib8","doi-asserted-by":"crossref","first-page":"581","DOI":"10.3389\/fimmu.2016.00581","article-title":"PD-L1 is not constitutively expressed on Tasmanian Devil Facial Tumor Cells but is strongly upregulated in response to IFN-\u03b3 and can be expressed in the tumor microenvironment","volume":"7","author":"Flies","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2021.108851_bib9","doi-asserted-by":"crossref","first-page":"11519","DOI":"10.1038\/s41598-018-29826-4","article-title":"Gomesin inhibits melanoma growth by manipulating key signaling cascades that control cell death and proliferation","volume":"8","author":"Ikonomopoulou","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.celrep.2021.108851_bib10","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1038\/bjc.2014.431","article-title":"In\u00a0vitro and in\u00a0vivo anticancer effects of mevalonate pathway modulation on human cancer cells","volume":"111","author":"Jiang","year":"2014","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.celrep.2021.108851_bib11","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ccell.2018.11.018","article-title":"The ERBB-STAT3 Axis Drives Tasmanian Devil Facial Tumor Disease","volume":"35","author":"Kosack","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2021.108851_bib12","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.cmet.2014.01.001","article-title":"Rapamycin: one drug, many effects","volume":"19","author":"Li","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.celrep.2021.108851_bib13","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1002\/hep.23436","article-title":"Down-regulation of the LXR transcriptome provides the requisite cholesterol levels to proliferating hepatocytes","volume":"51","author":"Lo Sasso","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.celrep.2021.108851_bib14","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1890\/08-1763.1","article-title":"Transmission dynamics of Tasmanian devil facial tumor disease may lead to disease-induced extinction","volume":"90","author":"McCallum","year":"2009","journal-title":"Ecology"},{"key":"10.1016\/j.celrep.2021.108851_bib15","doi-asserted-by":"crossref","first-page":"5246","DOI":"10.1158\/0008-5472.CAN-07-6161","article-title":"Mitochondrial cholesterol contributes to chemotherapy resistance in hepatocellular carcinoma","volume":"68","author":"Montero","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.celrep.2021.108851_bib16","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1180616","article-title":"The Tasmanian devil transcriptome reveals Schwann cell origins of a clonally transmissible cancer","volume":"327","author":"Murchison","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.celrep.2021.108851_bib17","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.cell.2011.11.065","article-title":"Genome sequencing and analysis of the Tasmanian devil and its transmissible cancer","volume":"148","author":"Murchison","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2021.108851_bib18","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.plipres.2016.09.002","article-title":"Oxysterols: From cholesterol metabolites to key mediators","volume":"64","author":"Mutemberezi","year":"2016","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.celrep.2021.108851_bib19","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1056\/NEJMoa1201735","article-title":"Statin use and reduced cancer-related mortality","volume":"367","author":"Nielsen","year":"2012","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.celrep.2021.108851_bib20","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nrm3512","article-title":"Caveolae as plasma membrane sensors, protectors and organizers","volume":"14","author":"Parton","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.celrep.2021.108851_bib21","doi-asserted-by":"crossref","first-page":"e0168068","DOI":"10.1371\/journal.pone.0168068","article-title":"The immunomodulatory small molecule imiquimod induces apoptosis in devil facial tumour cell lines","volume":"11","author":"Patchett","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.celrep.2021.108851_bib22","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/439549a","article-title":"Allograft theory: transmission of devil facial-tumour disease","volume":"439","author":"Pearse","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2021.108851_bib23","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0092-8674(00)81432-4","article-title":"Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha","volume":"93","author":"Peet","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2021.108851_bib24","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1016\/j.ajpath.2014.03.006","article-title":"Hypercholesterolemia induces angiogenesis and accelerates growth of breast tumors in\u00a0vivo","volume":"184","author":"Pelton","year":"2014","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.celrep.2021.108851_bib25","doi-asserted-by":"crossref","first-page":"e65133","DOI":"10.1371\/journal.pone.0065133","article-title":"Vincristine chemotherapy trials and pharmacokinetics in Tasmanian devils with Tasmanian devil facial tumor disease","volume":"8","author":"Phalen","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.celrep.2021.108851_bib26","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.tvjl.2015.10.013","article-title":"Doxorubicin and carboplatin trials in Tasmanian devils (Sarcophilus harrisii) with Tasmanian devil facial tumor disease","volume":"206","author":"Phalen","year":"2015","journal-title":"Vet. J."},{"key":"10.1016\/j.celrep.2021.108851_bib27","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1038\/onc.2010.30","article-title":"Liver X Receptor activation downregulates AKT survival signaling in lipid rafts and induces apoptosis of prostate cancer cells","volume":"29","author":"Pommier","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.celrep.2021.108851_bib28","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.semcancer.2017.04.011","article-title":"Inhibition of Akt and other AGC kinases: A target for clinical cancer therapy?","volume":"48","author":"Pr\u00eatre","year":"2018","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.celrep.2021.108851_bib29","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/s10393-007-0126-0","article-title":"Towards a case definition for Devil Facial Tumour Disease: What is it?","volume":"4","author":"Pyecroft","year":"2007","journal-title":"EcoHealth"},{"key":"10.1016\/j.celrep.2021.108851_bib30","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00280-012-2045-1","article-title":"A phase I dose-escalation trial of 2-deoxy-D-glucose alone or combined with docetaxel in patients with advanced solid tumors","volume":"71","author":"Raez","year":"2013","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.celrep.2021.108851_bib31","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1038\/sj.onc.1202322","article-title":"Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53","volume":"17","author":"Rao","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.celrep.2021.108851_bib32","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1146\/annurev.cellbio.16.1.459","article-title":"The role of orphan nuclear receptors in the regulation of cholesterol homeostasis","volume":"16","author":"Repa","year":"2000","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.celrep.2021.108851_bib33","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/nm1102-1243","article-title":"The liver X receptor gene team: potential new players in atherosclerosis","volume":"8","author":"Repa","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2021.108851_bib34","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0022-2275(20)32113-1","article-title":"Cell cholesterol efflux: integration of old and new observations provides new insights","volume":"40","author":"Rothblat","year":"1999","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.celrep.2021.108851_bib35","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S1388-1981(00)00142-6","article-title":"Oxysterol biosynthetic enzymes","volume":"1529","author":"Russell","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.celrep.2021.108851_bib36","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1093\/embo-reports\/kvf238","article-title":"Liver receptor homolog 1 controls the expression of the scavenger receptor class B type I","volume":"3","author":"Schoonjans","year":"2002","journal-title":"EMBO Rep."},{"key":"10.1016\/j.celrep.2021.108851_bib37","doi-asserted-by":"crossref","first-page":"e25235","DOI":"10.4161\/onci.25235","article-title":"How the devil facial tumor disease escapes host immune responses","volume":"2","author":"Siddle","year":"2013","journal-title":"OncoImmunology"},{"key":"10.1016\/j.celrep.2021.108851_bib38","doi-asserted-by":"crossref","first-page":"5103","DOI":"10.1073\/pnas.1219920110","article-title":"Reversible epigenetic down-regulation of MHC molecules by devil facial tumour disease illustrates immune escape by a contagious cancer","volume":"110","author":"Siddle","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2021.108851_bib39","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.coph.2012.10.004","article-title":"Cholesterol metabolism and cancer: the good, the bad and the ugly","volume":"12","author":"Silvente-Poirot","year":"2012","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.celrep.2021.108851_bib40","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1126\/science.290.5497.1721","article-title":"How cells handle cholesterol","volume":"290","author":"Simons","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.celrep.2021.108851_bib41","doi-asserted-by":"crossref","first-page":"a004697","DOI":"10.1101\/cshperspect.a004697","article-title":"Membrane organization and lipid rafts","volume":"3","author":"Simons","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.celrep.2021.108851_bib42","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/ncb2936","article-title":"Metabolic control of YAP and TAZ by the mevalonate pathway","volume":"16","author":"Sorrentino","year":"2014","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.celrep.2021.108851_bib43","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.ccell.2018.03.013","article-title":"The Origins and Vulnerabilities of Two Transmissible Cancers in Tasmanian Devils","volume":"33","author":"Stammnitz","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2021.108851_bib44","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1006\/bbrc.2001.5146","article-title":"Fatty acid synthase inhibition in human breast cancer cells leads to malonyl-CoA-induced inhibition of fatty acid oxidation and cytotoxicity","volume":"285","author":"Thupari","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.celrep.2021.108851_bib45","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1200\/JCO.2011.36.0917","article-title":"Statins and the risk of hepatocellular carcinoma in patients with hepatitis B virus infection","volume":"30","author":"Tsan","year":"2012","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.celrep.2021.108851_bib46","doi-asserted-by":"crossref","first-page":"12097","DOI":"10.1073\/pnas.200367697","article-title":"Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha","volume":"97","author":"Venkateswaran","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2021.108851_bib47","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.ccell.2016.09.008","article-title":"An LXR-Cholesterol Axis Creates a Metabolic Co-Dependency for Brain Cancers","volume":"30","author":"Villa","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2021.108851_bib48","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1194\/jlr.M500454-JLR200","article-title":"Overexpression of estrogen receptor alpha increases hepatic cholesterogenesis, leading to biliary hypersecretion in mice","volume":"47","author":"Wang","year":"2006","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.celrep.2021.108851_bib49","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ccr.2006.09.006","article-title":"Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance","volume":"10","author":"Wei","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2021.108851_bib50","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/hep.28712","article-title":"Farnesoid X receptor activation increases reverse cholesterol transport by modulating bile acid composition and cholesterol absorption in mice","volume":"64","author":"Xu","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.celrep.2021.108851_bib51","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1126\/science.1168974","article-title":"LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor","volume":"325","author":"Zelcer","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.celrep.2021.108851_bib52","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1161\/ATVBAHA.114.304267","article-title":"Cholesterol and lipoprotein metabolism: Early Career Committee contribution","volume":"34","author":"Zhang","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.celrep.2021.108851_bib53","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1158\/1940-6207.CAPR-09-0059","article-title":"Atorvastatin and celecoxib in combination inhibits the progression of androgen-dependent LNCaP xenograft prostate tumors to androgen independence","volume":"3","author":"Zheng","year":"2010","journal-title":"Cancer Prev. Res. (Phila.)"}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124721001650?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124721001650?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T11:12:59Z","timestamp":1761909179000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124721001650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":53,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S2211124721001650"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2021.108851","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LXR stimulates a metabolic switch and reveals cholesterol homeostasis as a statin target in Tasmanian devil facial tumor disease","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2021.108851","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"108851"}}